Regenative Labs Highlights Advancements in Post-Surgical Breast Reduction
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
The Clear + Brilliant Touch laser, cleared by the FDA in 2022, includes two wavelengths designed to address wrinkles, pigmentation, and skin texture.